News

NewYork-Presbyterian and Walgreens are collaborating to bring convenient access to NewYork-Presbyterian’s world-class care through new telemedicine services, now available through Walgreens digital properties and at self-service kiosks at select Duane Reade drugstores in New York. 

Patients with acute myeloid leukemia (AML) may have genetic mutations in their blood indicating they are at high risk of developing the disease about nine years before diagnosis, according to research from Weill Cornell Medicine and NewYork-Presbyterian investigators. 

Researchers and students from the Ithaca and Weill Cornell Medicine campuses met Nov. 30-Dec. 1 to collaborate and present research related to RNA, genetic material that is essential to coding, decoding, regulation and expression of genes.

Integrating human rights education into the medical school curriculum may strengthen medical ethics with regards to physician participation in and acceptance of torture, according to the results of a new study from students and faculty from the Weill Cornell Center for Human Rights. 

Dr. Said Ibrahim, a leading physician-scientist whose research focuses on healthcare disparities, has been named the inaugural chief of the newly established Division of Healthcare Delivery Science and Innovation in the Department of Healthcare Policy and Research at Weill Cornell Medicine, effective Feb. 1.

The Integrative Health and Wellbeing program at NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, provides patients with a customized “whole person approach” that addresses not just their physical state, but also their emotional, environmental and social wellbeing.

Awards, honors, prizes and achievements for the month of November.

Delirium is a frequent occurrence among children hospitalized with cancer, affecting nearly one in five patients.

Dr. Jessica Tyler has been elected a fellow of the American Association for the Advancement of Science. 

As a Cuban immigrant, Dr. Fernando Martinez seized opportunities the United States afforded him. Now a pulmonologist and parent, he’s dedicated his career to helping others, and has inspired his children to do the same.

Weill Cornell Medicine researchers have received a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to conduct an in-depth study of the mechanisms that cause scar tissue to form in the lung and kidney.

A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to a finding by Weill Cornell Medicine researchers.

Cornell scientists are working to improve radiation therapy.

Antibiotic treatment for Tuberculosis dramatically reduces quantities of several bacteria associated with immune system functions for at least a year, according to a study by scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Dr. Catherine Lord, director of the Center for Autism and the Developing Brain, a collaboration between Weill Cornell Medicine, NewYork-Presbyterian, and Columbia University College of Physicians and Surgeons, received the prestigious Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine.

Advances in scientific innovation are leading to powerful discoveries about Alzheimer’s and neurodegenerative diseases, sparking hope for the development of new treatment and therapies for the conditions.

Using techniques pioneered at Weill Cornell Medicine, scientists have captured the first video recordings of a key protein whose function is essential to a deadly foodborne bacteria.

Newer, non-chemotherapy drugs benefit many patients with mantle cell lymphoma, an incurable form of blood cancer, and deserve deeper study in clinical trials, according to an editorial published Sept. 12 in Blood by scientists at Weill Cornell Medicine and NewYork-Presbyterian.

Dr. Anthony Hollenberg, a leading physician-scientist specializing in endocrinology, has been appointed chairman of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.